Skip to main content

Table 1 Demographic and risk factors for sPTB among all participants and according to specific progesterone treatment

From: Progesterone therapy for prevention of recurrent spontaneous preterm birth in a minority patient population: a retrospective study

 

Total (N = 637)

Any Progesterone (N = 348)

ap-value

17-OHPC (N = 296)

bp-value

Vaginal Progesterone (N = 42)

cp-value

No treatment (N = 287)

Demographic factors and reproductive history before the index pregnancy

 Age

30.8 ± 6.0

31.0 ± 6.0

0.17

31.0 ± 6.1

0.25

30.7 ± 5.2

0.5

30.5 ± 5.9

 Gravida

4 (3–5)

4 (3–5)

0.012

4 (3–5)

< .001

4 (3–5)

0.615

4 (3–6)

 Parity

2 (1–3)

2 (1–3)

< .001

2 (1–2)

< .001

2 (1–3)

0.0441

2 (1–3)

dRace/Ethnicity

  

e0.89

 

e0.73

 

e0.49

 

 Non-Hispanic White

29 (4.6)

16 (4.6)

 

11 (3.7)

 

4 (9.5)

 

14 (4.6)

 Non-Hispanic Black

75 (11.8)

41 (11.8)

 

34 (11.4)

 

6 (14.3)

 

34 (11.8)

 Hispanic/Latina

460 (72.2)

258 (74.1)

 

223 (75.0)

 

28 (66.7)

 

201 (69.8)

 Asian/Pacific Islander

13 (2.0)

8 (2.3)

 

8 (2.7)

 

0 (0)

 

5 (1.7)

 Other

50 (7.8)

23 (6.6)

 

19 (6.4)

 

3 (7.1)

 

27 (9.4)

 BMI

31.9 ± 7.1

32.1 ± 7.6

0.5

32.3 ± 7.7

0.36

30.1 ± 6.8

0.76

31.5 ± 6.4

 Term delivery number

1 (0–2)

1 (0–1)

< .001

1 (0–1)

< .001

1 (0–2)

0.367

1 (0–2)

 Preterm delivery number

1 (1–2)

1 (1–2)

0.829

1 (1–2)

0.798

1 (1–2)

0.808

1 (1–2)

Demonstrated and Proposed Risk Factors for sPTB

 Total Maternal weight gain

10.7 ± 6.4

10.4 ± 6.3

0.67

10.7 ± 6.6

0.65

9.1 ± 4.5

0.82

11.2 ± 6.7

 Gestational age of earliest sPTB

32 (27–35)

32 (25–35)

< .001

32 (26–34)

< .001

32 (27–35)

0.044

34 (30–36)

 Number of spontaneous preterm births 1

498 (78.2)

275 (79.0)

 

234 (78.8)

 

35 (83.3)

 

222 (77.1)

 2

102 (16.0)

53 (15.2)

 

44 (14.8)

 

6 (14.3)

 

49 (17.0)

 3 or more

37 (5.8)

20 (5.7)

0.89

19 (6.4)

0.89

1 (2.4)

0.93

17 (5.9)

 Chronic Hypertension

53 (8.3)

29 (8.3)

0.47

26 (8.6)

0.63

3 (7.1)

0.63

24 (8.3)

 Pregestational Diabetes

50 (7.8)

34 (9.8)

0.026

31 (10.4)

0.034

2 (4.8)

0.2

16 (5.6)

 Short Cervix

74 (11.6)

59 (17.0)

< .001

45 (15.2)

< .001

10 (23.8)

0.001

15 (5.2)

 Tobacco Use

42 (6.6)

15 (4.3)

0.055

14 (4.7)

0.054

1 (2.4)

0.89

27 (9.4)

 Alcohol Use

7 (1.1)

4 (1.1)

1

3 (1.0)

1

0 (0)

1

3 (1.0)

 Illicit Substance Use

67 (10.5)

32 (9.2)

0.094

29 (9.8)

0.17

3 (7.1)

0.4

35 (12.2)

 Short inter-pregnancy interval

76 (11.9)

43 (12.4)

0.92

37 (12.5)

0.94

4 (9.5)

0.79

33 (11.5)

 UTI

155 (24.3)

103 (27.0)

0.25

75 (25.3)

0.45

14 (33.3)

0.17

62 (21.5)

 STI

60 (9.4)

32 (9.2)

0.69

26 (8.8)

0.61

6 (14.3)

0.71

28 (9.7)

 BV

91 (14.3)

63 (18.1)

0.002

53 (17.8)

0.007

8 (19.0)

0.016

28 (9.7)

 Antepartum vaginal bleeding

43 (6.8)

26 (7.5)

0.69

23 (7.7)

0.7

2 (4.8)

1

17 (5.9)

 Prior LEEP or CKC

7 (1.1)

2 (0.6)

0.43

2 (0.7)

0.36

1 (2.4)

1

5 (1.7)

 History of uterine instrumentation

93 (14.6)

58 (16.7)

0.17

48 (16.2)

0.24

8 (19.0)

0.28

35 (12.2)

 Periodontal Disease

5 (0.8)

2 (0.6)

1

1 (0.3)

0.56

1 (2.4)

0.35

3 (1.0)

 Limited prenatal care (< 5 visits)

83 (13.0)

11 (3.2)

< .001

8 (2.7)

< .001

2 (4.8)

0.011

72 (25.0)

 Gestational Diabetes

67 (10.5)

43 (12.4)

0.26

35 (11.8)

0.42

6 (14.3)

0.28

24 (8.3)

  1. ap value is any progesterone compared to no treatment
  2. bp value is 17OHPC compared to no treatment
  3. cp value is vaginal progesterone compared to no treatment
  4. d16 missing race
  5. ep value for trend